• Font Size    
E-mail

Close Window E-mail This Page

FDA Issues Public Health Advisory For Chantix

Required fields are marked with an asterisk(*)

The information you provide will be used only to send the requested e-mail and will not be used to send any other e-mail communications. Read more in our Privacy Policy

Send E-mail

   Print     Share +   
Feb 1, 2008 2:28 pm US/Central

FDA Issues Public Health Advisory For Chantix

WASHINGTON, D.C. (CBS 11 / TXA 21) ― Today the U.S. Food and Drug Administration issued a Public Health Advisory for Chantix, the controversial anti-smoking drug.

In a news release Friday, the FDA said "it appears increasingly likely that there may be an association between Chantix and serious neuropsychiatric symptoms."  The FDA says because of that, it has asked Pfizer, the maker of Chantix, to increase the prominence of the safety warnings on its packaging.

Just two weeks ago, Pfizer changed the drug's label to warn patients about possible serious side effects.  The company says patients on Chantix should be monitored for changes in behavior, agitation, depressed mood, suicidal ideation and suicidal behavior.

CBS 11 has been covering reported problems with Chantix for months, and our stories have unveiled many stories of problems reported by users of the drug.  Look at the "Related Stories" list to the right for these stories.

(© MMIX, CBS Broadcasting Inc. All Rights Reserved.)

You need the latest Flash player to view video content.
Click here to download.

Click here to bypass this detection if you already have the latest Flash Player.

Medical News

Top News Stories

© MMIX, CBS Stations Group of Texas L.P. All Rights Reserved.